FORM DEF 14A

Company

Celldex Therapeutics, Inc.

Filed

March 28, 2000

Period of Report

May 8, 2000

Accession Number

0000912057-00-014070

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →